Research Paper Volume 13, Issue 16 pp 20218—20228

ERCC6L promotes cell growth and metastasis in gastric cancer through activating NF-κB signaling

ERCC6L expression in GC tissues. (A) qRT-PCR detection of ERCC6L mRNA expression in GC tissues and adjacent normal tissues. (B) Western blot analysis of ERCC6L protein expression in tumor tissues (T) and matched normal tissues (N). (C) IHC analysis of ERCC6L expression in GC tissues and matched normal tissues. (D) Chi-square analysis of ERCC6L expression in GC tissues and adjacent non-tumor tissues based on IHC staining scores. (E) Kaplan-Meier analysis of overall survival for GC patients with different levels of ERCC6L expression. (F) Kaplan-Meier analysis of disease-free survival for GC patients with different levels of ERCC6L expression. *P

Figure 1. ERCC6L expression in GC tissues. (A) qRT-PCR detection of ERCC6L mRNA expression in GC tissues and adjacent normal tissues. (B) Western blot analysis of ERCC6L protein expression in tumor tissues (T) and matched normal tissues (N). (C) IHC analysis of ERCC6L expression in GC tissues and matched normal tissues. (D) Chi-square analysis of ERCC6L expression in GC tissues and adjacent non-tumor tissues based on IHC staining scores. (E) Kaplan-Meier analysis of overall survival for GC patients with different levels of ERCC6L expression. (F) Kaplan-Meier analysis of disease-free survival for GC patients with different levels of ERCC6L expression. *P < 0.05.